Insiders · BKYI

Cameron E. Williams

Director at Bio Key International Inc (BKYI) since June 2023

Cameron E. Williams has filed 9 insider reports with the SEC since June 2023, as director at Bio Key International Inc (BKYI). The latest filing, on May 27, 2025, reports grant or award at Bio Key International Inc (BKYI).

Filings
9
Companies
1
Bought on market
None
Sold on market
None

Companies where Cameron E. Williams is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Bio Key International Inc logo
BKYI
Bio Key International Inc
Directorsince June 202321,950$2.00May 27, 2025

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Cameron E. Williams with

Other insiders at the same companies

Questions about Cameron E. Williams

What is Cameron E. Williams's role at Bio Key International Inc?
Cameron E. Williams reports to the SEC as director at Bio Key International Inc (BKYI), according to the latest filing on May 27, 2025.
How many shares does Cameron E. Williams own?
After the latest filing that states it, Cameron E. Williams directly owned 21,950 shares of Bio Key International Inc (BKYI). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Cameron E. Williams bought or sold stock recently?
No open-market purchases or sales by Cameron E. Williams are on file. The filings report grant or award.
How do I get alerts when Cameron E. Williams files?
Follow Cameron E. Williams on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Cameron E. Williams (SEC CIK 0001976008). Totals count each trade once, skipping amendments whose original is on file, from Jun 12, 2023 on. View on SEC EDGAR · Get this as JSON